Current status: 1125 hESC lines, 7844 hiPSC lines, and 205 clinical studies, and 2403 certificates
Monthly statistic from May 1, 2026
Posted on May 1, 2026
| total lines | 8969 |
| hESC lines | 1125 |
| hiPSC lines | 7844 |
| derivation countries | 52 |
| projects | 342 |
| providers | 1047 |
| clinical studies | 205 |
| subclones | 4038 |
| certificates | 2403 |
| cell line certificates | 2246 |
| project certificates | 157 |